Clinical trial
Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual…
NCT00162786 · J. Uriach and Company, Industry · Terminated
Key facts
| NCT number | NCT00162786 |
|---|---|
| Title | Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance |
| Official title | Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance |
| Lead sponsor | J. Uriach and Company, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Rupatadine, Hydroxyzine, Placebo |
| Enrollment | 20 |
| Start date | May 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 13, 2005 |
| Last update posted | Oct 20, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: